Obesity-related cardiovascular disease: Implications of obstructive sleep apnea

R. Wolk, Virend Somers

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Obesity and obstructive sleep apnea (OSA) often coexist. OSA has been linked to cardiovascular disease. Thus, OSA may contribute to the cardiovascular consequences of obesity. In this review, we explore clinical and pathophysiological interactions between obesity, cardiovascular disease and OSA. We discuss the mechanisms whereby OSA may contribute to hypertension, atherosclerosis, insulin resistance and atrial fibrillation associated with obesity, and emphasize the potential implications for understanding why only a subgroup of obese patients develop cardiovascular disease. Identification of the OSA-dependent and OSA-independent pathways in the cardiovascular pathophysiology of obesity may hold clinical and therapeutic promise.

Original languageEnglish (US)
Pages (from-to)250-260
Number of pages11
JournalDiabetes, Obesity and Metabolism
Volume8
Issue number3
DOIs
StatePublished - May 2006

Fingerprint

Obstructive Sleep Apnea
Cardiovascular Diseases
Obesity
Atrial Fibrillation
Insulin Resistance
Atherosclerosis
Hypertension

Keywords

  • Cardiovascular disease
  • Obesity
  • Sleep apnea

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Obesity-related cardiovascular disease : Implications of obstructive sleep apnea. / Wolk, R.; Somers, Virend.

In: Diabetes, Obesity and Metabolism, Vol. 8, No. 3, 05.2006, p. 250-260.

Research output: Contribution to journalArticle

@article{9a8e1b70edba4955a5d19de2532e9b56,
title = "Obesity-related cardiovascular disease: Implications of obstructive sleep apnea",
abstract = "Obesity and obstructive sleep apnea (OSA) often coexist. OSA has been linked to cardiovascular disease. Thus, OSA may contribute to the cardiovascular consequences of obesity. In this review, we explore clinical and pathophysiological interactions between obesity, cardiovascular disease and OSA. We discuss the mechanisms whereby OSA may contribute to hypertension, atherosclerosis, insulin resistance and atrial fibrillation associated with obesity, and emphasize the potential implications for understanding why only a subgroup of obese patients develop cardiovascular disease. Identification of the OSA-dependent and OSA-independent pathways in the cardiovascular pathophysiology of obesity may hold clinical and therapeutic promise.",
keywords = "Cardiovascular disease, Obesity, Sleep apnea",
author = "R. Wolk and Virend Somers",
year = "2006",
month = "5",
doi = "10.1111/j.1463-1326.2005.00508.x",
language = "English (US)",
volume = "8",
pages = "250--260",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Obesity-related cardiovascular disease

T2 - Implications of obstructive sleep apnea

AU - Wolk, R.

AU - Somers, Virend

PY - 2006/5

Y1 - 2006/5

N2 - Obesity and obstructive sleep apnea (OSA) often coexist. OSA has been linked to cardiovascular disease. Thus, OSA may contribute to the cardiovascular consequences of obesity. In this review, we explore clinical and pathophysiological interactions between obesity, cardiovascular disease and OSA. We discuss the mechanisms whereby OSA may contribute to hypertension, atherosclerosis, insulin resistance and atrial fibrillation associated with obesity, and emphasize the potential implications for understanding why only a subgroup of obese patients develop cardiovascular disease. Identification of the OSA-dependent and OSA-independent pathways in the cardiovascular pathophysiology of obesity may hold clinical and therapeutic promise.

AB - Obesity and obstructive sleep apnea (OSA) often coexist. OSA has been linked to cardiovascular disease. Thus, OSA may contribute to the cardiovascular consequences of obesity. In this review, we explore clinical and pathophysiological interactions between obesity, cardiovascular disease and OSA. We discuss the mechanisms whereby OSA may contribute to hypertension, atherosclerosis, insulin resistance and atrial fibrillation associated with obesity, and emphasize the potential implications for understanding why only a subgroup of obese patients develop cardiovascular disease. Identification of the OSA-dependent and OSA-independent pathways in the cardiovascular pathophysiology of obesity may hold clinical and therapeutic promise.

KW - Cardiovascular disease

KW - Obesity

KW - Sleep apnea

UR - http://www.scopus.com/inward/record.url?scp=33645469667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645469667&partnerID=8YFLogxK

U2 - 10.1111/j.1463-1326.2005.00508.x

DO - 10.1111/j.1463-1326.2005.00508.x

M3 - Article

C2 - 16634984

AN - SCOPUS:33645469667

VL - 8

SP - 250

EP - 260

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 3

ER -